Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Generic Cardio Drugs Equal Brands
By:
Mike Havrilla
Tuesday, December 02, 2008 6:29 PM
Symbols:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
Email Article
Bookmark:
Font Size
Print Article
The Top 30 Rated Healthcare Cost Containment companies outpaced benchmark healthcare ETFs over the past year with a loss of just 2.7%, compared to losses of about 30% each for the Healthcare Sector SPDR (XLV) and iShares S&P Global Healthcare (IXJ), 18% for PowerShares Dynamic Pharma (PJP), 28% for Pharma HOLDRs, and 22% for iShares Dow Jones U.S. Pharma (IHE).
Next Page >>
<< Previous Page
1
2
Bookmark:
Email Article
Print Article
Related Stories
Research Related Stocks:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
,
More Articles on:
Medical
US Stock Futures Point To Higher Open, Tiffany (NYSE: TIF) Eyed
As Bank Failures Grow, FDIC Options Narrow
Is Tech Over-Valued?
Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance
Can U.S. Bank Stocks Double Again In 2010?
Rate this Commentary
Comments
(0)
No Comments
Post Comment
Name:
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
Advertisement
Related Press Releases
NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
Teva Receives Final Approval for Generic Prevacid® Delayed-Release Capsules
Teva Receives Favorable Court Decision Regarding Generic Prevacid® SoluTab
Market Watch: Sunwin International Neutraceuticals - November 10, 2009
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents
Popular Articles
Can U.S. Bank Stocks Double Again In 2010?
By:
Money Morning
Warning: You May Not Be Making As Much On Gold As You Think
By:
Money Morning
Ten Reasons For Buying Activision Blizzard (ATVI)
By:
Asif Suria
Bears In Trouble? Super Dividends
By:
Marc Courtenay
A Winning Investment Strategy
By:
Dividends4Life
Advertisement
Recent Articles by Mike Havrilla
Synta Pharma Proceeds with Clinical Trial
Cytori Therapeutics: Stock Profile and 2009 Outlook
Research Note on Synta Pharma (SNTA)
Trading FDA Decisions: 14 Extreme Trades
Stem Cell Index Soars on Lift of Funding Ban
Global Stem Cell and Regenerative Medicine Index
Advertisement
More Articles by:
Mike Havrilla
More Articles on:
Medical
Research Related Stocks:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
,
Subscribe to
Email Alerts
or
RSS feeds
for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia